v3.22.4
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Nov. 30, 2022
Nov. 30, 2021
Cash Flows From Operating Activities    
Net loss $ (3,968,106) $ (700,908)
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 863,322 904,972
Provision for obsolete inventory 166,255 103,422
Provision for loss on accounts and notes receivable (119,000) 0
Gain on sale or disposal of property and equipment (14,403) (153,129)
Expense recorded for stock compensation 471,530 709,210
Deferred income taxes 1,388,271 (426,041)
Changes in operating assets and liabilities:    
Accounts receivable (1,171,146) (985,887)
Refundable income taxes 303,779 1,168
Inventories (2,091,099) (936,483)
Contract liabilities 4,500 23,048
Other current assets (109,860) (105,851)
Accounts payable 1,976,869 1,079,671
Accrued liabilities (1,284,330) 1,343,856
Net cash (used in) provided by operating activities (3,583,418) 857,048
Addition to notes receivable (58,635) 0
Proceeds received on notes receivable 49,254 98,918
Proceeds from sale or disposal of assets 22,289 1,751
Proceeds from insurance recovery 0 206,336
Purchases of property and equipment (810,732) (704,462)
Decrease (Increase) in other assets 10,000 (10,000)
Net cash used in investing activities (787,824) (407,457)
Cash Flows from Financing Activities    
Dividends paid and redemption of outstanding preferred stock purchase rights 0 (61,276)
Net cash used in financing activities 0 (61,276)
Net (Decrease) Increase in Cash and Cash Equivalents (4,371,242) 388,315
Cash and Cash Equivalents, Beginning of Period 7,587,374 5,633,279
Cash and Cash Equivalents, End of Period $ 3,216,132 $ 6,021,594

Source